European Lower Midcap PE Investing in Longevity and Hormones

In this episode of Private Equity Dealbook, Elana Margulies-Snyderman, Director, Publications, speaks with Karen O’Mahony, Managing Partner, PEAL Capital Group, a female-founded European-based lower midcap private equity firm specializing in control investments in the rapidly growing sector of longevity and hormones. Karen discusses the transactions PEAL has completed with Derma Medical, a leading aesthetic training provider and GLHMs, a medical training platform for longevity, hormones and menopause, including the processes, opportunities and challenges when it came to the deals. She also discusses how she navigated the due diligence process and more.